Literature DB >> 26951120

Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.

Alessandro Galazzi1, Maura Lusignani2,3, Maria Teresa Chiarelli4, Pier Mannuccio Mannucci5,6, Carlotta Franchi7, Mauro Tettamanti7, Emily Reeve8,9, Alessandro Nobili7.   

Abstract

BACKGROUND: From 20 to 65 % of older adults receiving polypharmacy take at least one potentially inappropriate medication (PIM), leading to a high risk of adverse drug reactions. The term deprescribing was coined to describe a process of optimization of drug regimens through the withdrawal of PIMs. There is a paucity of evidence on the attitudes, beliefs and willingness of hospitalized patients towards deprescribing.
OBJECTIVE: To measure at hospital discharge inpatients' attitudes and beliefs towards polypharmacy and the potential withdrawal of one or more of their medications using the PATD (Patients' Attitudes Towards Deprescribing) questionnaire and determine if they are associated with participant characteristics.
SETTING: Geriatric and internal medicine wards in an Italian teaching hospital.
METHOD: Administration of the PATD questionnaire (developed and validated in an Australian outpatient setting, translated and adapted to the Italian setting for this study) to a consecutive sample of 100 older (aged ≥65 years) inpatients with polypharmacy who were interviewed by a nurse or pharmacist at the time of hospital discharge. MAIN OUTCOME MEASURE: Older patients' attitudes and beliefs towards reducing medications and participant characteristics.
RESULTS: Eighty-nine percent of patients surveyed would like to reduce the number of daily medications. The desire for deprescribing was not associated with age, sex or number of medications or medical conditions; older patients were less aware of the reasons for taking medications.
CONCLUSION: The majority of hospitalized older adults with polypharmacy think they are taking a lot of drugs and would like to reduce this number. Older adults should not be considered a major limitation on deprescribing interventions. Future research should examine this issue with qualitative studies in order to gain a more in-depth understanding and explore how these findings can be translated into a multidisciplinary deprescribing process.

Entities:  

Keywords:  Deprescribing; Italy; Older adults; Patient attitudes; Polypharmacy; Potentially inappropriate medications (PIMs); Withdrawal

Mesh:

Year:  2016        PMID: 26951120     DOI: 10.1007/s11096-016-0279-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  26 in total

1.  People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe.

Authors:  Emily Reeve; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib
Journal:  J Am Geriatr Soc       Date:  2013-08-26       Impact factor: 5.562

Review 2.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Susan M Patterson; Carmel Hughes; Ngaire Kerse; Chris R Cardwell; Marie C Bradley
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Medication management: older people and nursing.

Authors:  Maggie Banning
Journal:  Nurs Older People       Date:  2005-10

Review 4.  Health outcomes and polypharmacy in elderly individuals: an integrated literature review.

Authors:  Susan C Frazier
Journal:  J Gerontol Nurs       Date:  2005-09       Impact factor: 1.254

Review 5.  Physicians need to take the lead in deprescribing.

Authors:  I A Scott; D G Le Couteur
Journal:  Intern Med J       Date:  2015-03       Impact factor: 2.048

6.  Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy.

Authors:  Doron Garfinkel; Derelie Mangin
Journal:  Arch Intern Med       Date:  2010-10-11

7.  The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people.

Authors:  Mark E Williams; Charles C Pulliam; Rebecca Hunter; Ted M Johnson; Justine E Owens; Jean Kincaid; Carol Porter; Gary Koch
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

8.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

Review 9.  Patient barriers to and enablers of deprescribing: a systematic review.

Authors:  Emily Reeve; Josephine To; Ivanka Hendrix; Sepehr Shakib; Michael S Roberts; Michael D Wiese
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

10.  Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.

Authors:  Emily Reeve; Sepehr Shakib; Ivanka Hendrix; Michael S Roberts; Michael D Wiese
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

View more
  31 in total

1.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.

Authors:  Parag Goyal; Tatiana Requijo; Birgit Siceloff; Megan J Shen; Ruth Masterson Creber; Sarah N Hilmer; Ian M Kronish; Mark S Lachs; Monika M Safford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

Review 2.  A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.

Authors:  Mouna Sawan; Emily Reeve; Justin Turner; Adam Todd; Michael A Steinman; Mirko Petrovic; Danijela Gnjidic
Journal:  Expert Rev Clin Pharmacol       Date:  2020-02-27       Impact factor: 5.045

3.  Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.

Authors:  Emily Reeve; Jennifer L Wolff; Maureen Skehan; Elizabeth A Bayliss; Sarah N Hilmer; Cynthia M Boyd
Journal:  JAMA Intern Med       Date:  2018-12-01       Impact factor: 21.873

Review 4.  Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili; Luca Pasina
Journal:  Intern Emerg Med       Date:  2018-08-31       Impact factor: 3.397

5.  Development and Validation of the Revised Patients' Attitudes Towards Deprescribing (rPATD) Questionnaire: Versions for Older Adults and Caregivers.

Authors:  Emily Reeve; Lee-Fay Low; Sepehr Shakib; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

6.  Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications.

Authors:  Takuya Aoki; Yosuke Yamamoto; Tatsuyoshi Ikenoue; Shunichi Fukuhara
Journal:  Int J Clin Pharm       Date:  2019-02-05

7.  Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.

Authors:  Steven Rowe; Nicole Pittman; Catherine Balsom; Rebecca Druken; Deborah V Kelly
Journal:  Int J Clin Pharm       Date:  2022-10-06

Review 8.  Deprescribing of non-antiretroviral therapy in HIV-infected patients.

Authors:  José-Ramón Blanco; Ramón Morillo; Vicente Abril; Ismael Escobar; Enrique Bernal; Carlos Folguera; Fátima Brañas; Mercedes Gimeno; Olatz Ibarra; José-Antonio Iribarren; Alicia Lázaro; Ana Mariño; María-Teresa Martín; Esteban Martinez; Luis Ortega; Julian Olalla; Aguas Robustillo; Matilde Sanchez-Conde; Miguel-Angel Rodriguez; Javier de la Torre; Javier Sanchez-Rubio; Montse Tuset
Journal:  Eur J Clin Pharmacol       Date:  2019-12-21       Impact factor: 2.953

9.  Older people's attitudes towards deprescribing cardiometabolic medication.

Authors:  Stijn Crutzen; Jamila Abou; Sanne E Smits; Gert Baas; Jacqueline G Hugtenburg; Mette Heringa; Petra Denig; Katja Taxis
Journal:  BMC Geriatr       Date:  2021-06-16       Impact factor: 3.921

10.  How Willing Are Patients or Their Caregivers to Deprescribe: a Systematic Review and Meta-analysis.

Authors:  Yee Lin Chock; Yuan Lin Wee; Su Lene Gan; Kah Woon Teoh; Khuen Yen Ng; Shaun Wen Huey Lee
Journal:  J Gen Intern Med       Date:  2021-06-25       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.